{
    "data": [
        {
            "id": "2768355",
            "type": "article",
            "attributes": {
                "publishOn": "2014-12-19T08:16:33-05:00",
                "isLockedPro": false,
                "commentCount": 40,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "DaVita's Outlook For 2015: Don't Overstay The Festivities",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "57342",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "147293",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": [
                        {
                            "id": "1302",
                            "type": "tag"
                        }
                    ]
                }
            },
            "links": {
                "self": "/article/2768355-davitas-outlook-for-2015-dont-overstay-the-festivities"
            }
        },
        {
            "id": "2688925",
            "type": "article",
            "attributes": {
                "publishOn": "2014-11-18T14:34:35-05:00",
                "isLockedPro": false,
                "commentCount": 13,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Intensity Is The Price Of Excellence: Davita Healthcare Partners And Evidence-Based Management",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "68465",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "145114",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2688925-intensity-is-the-price-of-excellence-davita-healthcare-partners-and-evidence-based-management"
            }
        },
        {
            "id": "2679945",
            "type": "article",
            "attributes": {
                "publishOn": "2014-11-14T16:44:34-05:00",
                "isLockedPro": false,
                "commentCount": 0,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "InsiderInsights.com Daily Round Up 11/12/14: DVA, PSEC, MRC, SUMR",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "27671",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2679945-insiderinsights-com-daily-round-up-11-12-14-dva-psec-mrc-sumr"
            }
        },
        {
            "id": "2661275",
            "type": "article",
            "attributes": {
                "publishOn": "2014-11-10T09:44:28-05:00",
                "isLockedPro": false,
                "commentCount": 9,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Update: DaVita Down On 2016 Outlook, Despite Excellent Cash Generation",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "56062",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2661275-update-davita-down-on-2016-outlook-despite-excellent-cash-generation"
            }
        },
        {
            "id": "2641055",
            "type": "article",
            "attributes": {
                "publishOn": "2014-11-05T03:50:26-05:00",
                "isLockedPro": false,
                "commentCount": 1,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "What To Expect During DaVita's Upcoming Earnings Announcement",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "61211",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2641055-what-to-expect-during-davitas-upcoming-earnings-announcement"
            }
        },
        {
            "id": "2376465",
            "type": "article",
            "attributes": {
                "publishOn": "2014-08-04T07:34:40-04:00",
                "isLockedPro": false,
                "commentCount": 6,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Update: DaVita Is Still Undervalued, Despite Headwinds",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "56062",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": []
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2376465-update-davita-is-still-undervalued-despite-headwinds"
            }
        },
        {
            "id": "2243693",
            "type": "article",
            "attributes": {
                "publishOn": "2014-05-29T11:48:16-04:00",
                "isLockedPro": false,
                "commentCount": 8,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "DaVita's Trial Of Nephros' HDF Dialysis Therapy Presents Opportunity For Both Firms",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "66093",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "134542",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2243693-davitas-trial-of-nephros-hdf-dialysis-therapy-presents-opportunity-for-both-firms"
            }
        },
        {
            "id": "2242203",
            "type": "article",
            "attributes": {
                "publishOn": "2014-05-28T16:50:29-04:00",
                "isLockedPro": false,
                "commentCount": 22,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "DaVita: Giving Life To Portfolios Since 2000, More To Come?",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "43971",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "134499",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2242203-davita-giving-life-to-portfolios-since-2000-more-to-come"
            }
        },
        {
            "id": "2102763",
            "type": "article",
            "attributes": {
                "publishOn": "2014-03-21T15:58:46-04:00",
                "isLockedPro": false,
                "commentCount": 1,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "DaVita: Short-Term Headwinds Could Create Buying Opportunity For Long-Term Investors",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "31831",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "131251",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3907",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/2102763-davita-short-term-headwinds-could-create-buying-opportunity-for-long-term-investors"
            }
        }
    ]
}